Skip to content

Bacterial Pathogens Associated With Community-acquired Pneumonia in Children

Bacterial Pathogens Associated With Community-acquired Pneumonia in Children

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06377163
Enrollment
100
Registered
2024-04-22
Start date
2021-01-01
Completion date
2021-08-31
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children Chest Infection

Brief summary

Pediatric community acquired pneumonia (CAP) is one of the most common reasons for hospital admission, there is no reliable way of distinguishing the causative organism based on clinical features. This study examined common pathogens of community-acquired pneumonia from 28 days up to 10 years in Dakahlia Governorate.

Interventions

None listed

Sponsors

Delta University for Science and Technology
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
28 Days to 10 Years

Inclusion criteria

\- Inclusion criteria: * Infants and children aged 28 days to ten years (male and female sexes). * Patients diagnosed with community-acquired pneumonia. * Pneumonia was diagnosed if the patient fulfilled has fever (temperature ≥38.3° C), Fast breathing (40 breaths per minute if the child is 1 year up to 10 years old), respiratory distress (tachypnea, retractions) and chest indrawing and cyanosis with compatible chest x-ray findings.

Exclusion criteria

* Neonates * Children more than 10 years * Hospital acquired pneumonia * Chronic lung disease, immunodeficiency and other congenital anomalies

Design outcomes

Primary

MeasureTime frameDescription
Complete blood countAt the baseline evaluationFrom each participant, a sample of 4 ml of fresh venous blood was collected from the peripheral vein by the sterile venipuncture technique & drawn into a vacuumed purple top tube containing an anticoagulant. It was performed using a fully automated hematology analyzer. This test measures the amounts and sizes of red blood cells, hemoglobin, white blood cells, and platelets. It will be aggregated to arrive at one report. Hemoglobin is usually reported in units of grams per liter, or grams per deciliter. The analyzer counts red blood cells, reporting the result in units of 106 cells per microliter of blood or 1012 cells per liter, and measures their average size, which is called the mean cell volume and expressed in femtoliters or cubic micrometers. The total white blood cell count is usually reported in cells per microliter of blood, or 109 cells per liter. The platelet count can be reported in units of cells per microliter of blood, 103 cells per microliter, or 109 cells per liter.
C-reactive protein (CRP)At the baseline evaluationIt was measured quantitatively in human serum by Beckman-Coulter AU Analyzers (USA). Sample preparation: 2 ml of blood in a sterile tube was centrifuged, then used immediately for CRP. C-reactive protein (CRP) is an annular (ring-shaped) pentameric protein found in blood plasma whose circulating concentrations rise in response to inflammation. Traditional CRP measurement only detected CRP in the range of 10 to 1,000 mg/L, whereas high-sensitivity CRP (hs-CRP) detects CRP in the range of 0.5 to 10 mg/L.
Blood culture and sensitivity on admissionAt the baseline evaluationIt was done using the BD Bactec 9050 Blood Culture System (USA, Catalog No. 445800) instrument. A culture was considered positive if any organism was identified.
Gastric lavage culture or sputum culture on admissionAt the baseline evaluationIt was inserted through the nose and down the stomach after nebulization with hypertonic saline at 5% for 10 seconds. Suction was applied for up to 15 seconds to collect the swallowed sputum in a sterile container. A culture was considered positive if any organism was identified.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026